Doç. Dr. İPEK EREN VURAL

Yayın Ağı

Makaleler 9

1. Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic

Vural I. E., Herder M., Doll A., Graham J. E.

International Journal of Health Policy and Management , cilt.12, sa.1, 2023 (SCI-Expanded, SSCI, Scopus)

2. From sandbox to pandemic: Agile reform of Canadian drug regulation

Eren Vural İ., Herder M., Graham J. E.

Health Policy , cilt.125, sa.9, ss.1115-1120, 2021 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

3. Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

Edmonds S., Macgregor A., Doll A., Vural İ., Graham J., Fierlbeck K., et al.

Journal of Law and the Biosciences , cilt.7, sa.1, 2020 (SCI-Expanded, SSCI, Scopus)

4. Financialisation in health care: An analysis of private equity fund investments in Turkey

EREN VURAL İ.

SOCIAL SCIENCE & MEDICINE , cilt.187, ss.276-286, 2017 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

5. Comparative Perspective on Financial System in the EU, Country Report on Turkey

TOPAL YILMAZ A., YALMAN O. G., BEDİRHANOĞLU TOKER P., EREN VURAL İ., CÖMERT H., Demizöz D., et al.

Econpapers , 2012 (Hakemsiz Dergi)

6. Domestic contours of global regulation: Understanding the policy changes on pharmaceutical patents in India and Turkey

Eren-Vural İ.

Review of International Political Economy , cilt.14, sa.1, ss.105-142, 2007 (SSCI, Scopus)

7. A Political Economy of the recent Changes in the Pharmaceutical Patent Policies across the Developing World and Turkey

EREN VURAL İ.

METU Studies in Development , cilt.34, sa.2, ss.337-385, 2007 (Hakemli Dergi)

8. Refah Devleti ve Sosyal Politikalar

EREN VURAL İ.

Toplum ve Hekim , cilt.20, sa.1, ss.20-27, 2005 (Hakemli Dergi)

9. Gelişmekte olan ülkeler ve Türkiye de İlaç Ürünlerine Yönelik Fikri Mülkiyet Rejimi Değişikliklerinin Siyasal İktisadı

EREN VURAL İ.

Toplum ve Hekim , cilt.19, sa.5, ss.383-393, 2004 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 8

1. “Biopharmaceutical Financialization and Public Funding of MCMs in Canada during COVID-19 Pandemic”

Eren Vural I.

Society for Social Studies of Science 2022 Annual Conference, 08 Aralık 2022, (Özet Bildiri)

2. “Regulatory Collaboration during COVID-19: Implications for the Future of Health Product Regulation”

Eren Vural I.

Fit for Purpose Regulation Policy Workshop, Dublin, İrlanda, 06 Kasım 2022, (Özet Bildiri)

3. “Competitive Interdependence: Political Economy of Drug Regulation during the Pandemic”

Eren Vural I.

Canadian Political Science Association Annual Conference, 2022, 02 Haziran 2022, (Özet Bildiri)

4. Financialisation and Private Equity Fund Investments in the Turkish Healthcare System

EREN VURAL İ.

7th Annual Conference of the International Initiative for the Promotion of Political Economy, Lizbon, Portekiz, 7 - 09 Eylül 2016, (Özet Bildiri)

5. Neoliberalizm Fikri Mülkiyet Hakları ve2000 liyıllarda Türk İlaç Sanayii

EREN VURAL İ.

13. Sosyal Bilimler Kongresi, Ankara, Türkiye, 4 - 06 Aralık 2013, (Tam Metin Bildiri)

6. A Political Economy of the recent Changes in the Pharmaceutical Patent Policies across the Developing World and Turkey

EREN VURAL İ.

British Political Studies Association 54th Annual Conference, LINCOLN, İngiltere, 5 - 08 Nisan 2004, (Tam Metin Bildiri)

7. Globalisation and Policy Change

EREN VURAL İ.

Policy and Politics International Conference, Policy and Politics in a Globalised World, Bristol, İngiltere, 24 - 26 Temmuz 2003, (Tam Metin Bildiri)

8. Could Corporatist Associations become Effective Channels of Interest Representation The Case of Turkish Union of Chamber of Pharmacists

EREN VURAL İ.

Middle East Studies Association of North America 35th Annual Meeting, San-Francisco, Kostarika, 17 - 21 Kasım 2001, (Tam Metin Bildiri)

Kitaplar 8

Bilirkişi Raporları 1

1. Comparative Perspective on Financial System in the EU Country Report on Turkey

YALMAN O. G., TOPAL YILMAZ A., BEDİRHANOĞLU TOKER P., CÖMERT H., EREN VURAL İ., EROL I., et al.

2016

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Doç. Dr. İPEK EREN VURAL

Yayınlar & Eserler

1. Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic

2. From sandbox to pandemic: Agile reform of Canadian drug regulation

3. Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

4. Financialisation in health care: An analysis of private equity fund investments in Turkey

5. Comparative Perspective on Financial System in the EU, Country Report on Turkey

6. Domestic contours of global regulation: Understanding the policy changes on pharmaceutical patents in India and Turkey

7. A Political Economy of the recent Changes in the Pharmaceutical Patent Policies across the Developing World and Turkey

8. Refah Devleti ve Sosyal Politikalar

9. Gelişmekte olan ülkeler ve Türkiye de İlaç Ürünlerine Yönelik Fikri Mülkiyet Rejimi Değişikliklerinin Siyasal İktisadı

1. “Biopharmaceutical Financialization and Public Funding of MCMs in Canada during COVID-19 Pandemic”

2. “Regulatory Collaboration during COVID-19: Implications for the Future of Health Product Regulation”

3. “Competitive Interdependence: Political Economy of Drug Regulation during the Pandemic”

4. Financialisation and Private Equity Fund Investments in the Turkish Healthcare System

5. Neoliberalizm Fikri Mülkiyet Hakları ve2000 liyıllarda Türk İlaç Sanayii

6. A Political Economy of the recent Changes in the Pharmaceutical Patent Policies across the Developing World and Turkey

7. Globalisation and Policy Change

8. Could Corporatist Associations become Effective Channels of Interest Representation The Case of Turkish Union of Chamber of Pharmacists

1. Restricted but significant:Financialisation of Households and Retail Banking Activities in Turkey

2. Politics, Reforms, and Regulation of Pharma Prices and Expenditures in Turkey over the 2000s.

3. İlaç Sanayiinde Fikri Mülkiyet Hakları Rejimi ile İlgili Mücadeleler ve Devletin Uluslararasılaşması

4. Neoliberalism, Intellectual Property Rights and the Turkish Pharmaceutical Industry in the 2000s.

5. Converging Europe: Transformation of Social Policy in the Enlarged European Union and in Turkey.

6. Lisbon Strategy and Social Policy in the Enlarged European Union and in Turkey

7. Social Outcomes of the Lisbon Strategy and Beyond

8. Siyasal İstikrarın Parlementer Kökenleri:İngiltere Üzerine bir Derleme

1. Comparative Perspective on Financial System in the EU Country Report on Turkey

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim